Eje cerebro-intestino y pentadecapéptido BPC 157: implicaciones teóricas y prácticas

Margarita

Guest
Miembro del equipo
Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865. doi:10.2174/1570159x13666160502153022
MLASikiric, Predrag et al. “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” Current neuropharmacology vol. 14,8 (2016): 857-865. doi:10.2174/1570159x13666160502153022
APASikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Starcevic, N., Krstonijevic, Z., Bencic, M. L., Filipcic, I., Rokotov, D. S., & Vlainic, J. (2016). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current neuropharmacology, 14(8), 857–865. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
 

Adjuntos

  • bpc157.en.es[3-9].pdf
    679 KB · Visitas: 0
Arriba